Is LivaNova PLC (LIVN) Overvalued?
We dive into why LivaNova PLC (LIVN) could be considered overvalued on 2026-07-29, based on AAII’s Value Score and Grade.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Commentary & Analysis
Which Is a Better Investment, Butterfly Network, Inc. or LivaNova PLC Stock?
Learn more about whether Butterfly Network, Inc. or LivaNova PLC is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Rosalio Madrigal
Why LivaNova PLC’s (LIVN) Stock Is Up 5.07%
As of Thursday, May 07, LivaNova PLC’s LIVN share price has surged by 5.07%, which has investors questioning if this is right time to sell.Jenna Brashear
Why LivaNova PLC’s (LIVN) Stock Is Up 15.42%
As of Wednesday, May 06, LivaNova PLC’s LIVN share price has surged by 15.42%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why LivaNova PLC’s (LIVN) Stock Is Up 13.60%
As of Wednesday, May 06, LivaNova PLC’s LIVN share price has surged by 13.60%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | LIVN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,452.4 | $334.8 | 65% |
|
| Shares Out (Mil) | 55.9 | 41.7 | 51% |
|
| Institutional Ownership | 99.6% | 77.3% | 91% |
|
| Float (Mil) | 54.7 | 34.7 | 49% |
|
| Beta | 0.82 | 0.86 | 48% |
|
| Avg Daily Volume (000s) | 522 | 266 | 60% |
|
| Price Change (52-week) |
84.3% | 60.7% | 90% |
|
| Growth | LIVN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.2% | 11.8% | 51% |
|
| Net Income (5yr) | 7.0% | (5.8%) | 50% |
|
| EPS (5yr) | 9.1% | 10.7% | 45 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (19.2%) | (16.1%) | 35% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 9 | 9 | 9 | |
| Current EPS | $1.094 | $4.251 | $4.633 | |
| Month Ago EPS | $1.091 | $4.249 | $4.631 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $1.092 | $4.211 | $4.572 | |
| Year/Year Chg | 173.5% | (195.5%) | (214.9%) | |
| Financials | LIVN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,434 | $152 | 56% |
|
| Net Income (TTM) (Mil) | $107 | ($11) | 61% |
|
| EPS (TTM) | $1.962 | ($0.500) | 71% |
|
| Operating Cash Flow (TTM) (Mil) | $246 | ($2) | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($199) | $1 | 10% |
|
| Long-Term Debt (Q1) (Mil) | $332 | $22 | 55% |
|
| Enterprise Value (Q1) (Mil) | $3,654 | $304 | 58% |
|
| Valuation | LIVN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.67 | 2.88 | 71% |
|
| P/E | 41.7 | 30.5 | 79% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 4.6 | 1.9 | 86% |
|
| Ratios | LIVN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 67.9% | 59.1% | 79% |
|
| Net Margin | 7.5% | (7.7%) | 57% |
|
| ROA | 4.2% | (13.7%) | 68% |
|
| ROE | 9.5% | (15.9%) | 56% |
|
| Liabilities to Assets | 51.9% | 44.9% | 44% |
|
| F-Score | 6 | 4 | 69% |
|
LivaNova PLC did not pass any screens on 7/30/2026.
